Why the study?
Does the renin inhibitor CGP 29,287 lower blood pressure and reduce active hormones of the renin-angiotensin system in normotensive marmosets on a low-salt diet?
Does the renin inhibitor CGP 29,287 lower blood pressure and reduce active hormones of the renin-angiotensin system in normotensive marmosets on a low-salt diet?
Prolonged renin inhibition with CGP 29,287 in marmosets effectively lowers blood pressure and suppresses Ang II and aldosterone formation despite a marked compensatory increase in renin release.
Answers are grounded in this paper and cite their sources.
Does not inform clinical practice; leaves open translation of renin inhibition to human hypertension.
The renin inhibitor CGP 29,287 was administered continuously for 7 days (30 mg/kg per day, intraperitoneally, via osmotic minipumps) to normotensive marmosets fed a low-salt diet. As a control, another group of marmosets was given vehicle only. After 7 days of treatment, the mean arterial blood pressure of the CGP 29,287-treated marmosets was significantly lowered by about 23 mmHg. Plasma immunoreactive total and active renin were increased 10- and sevenfold, respectively, whereas plasma renin activity (PRA) was reduced by 95%. Plasma angiotensin II (Ang II) and aldosterone were also reduced (by 97 and 85%, respectively). Serum angiotensin converting enzyme activity was unchanged and there were no differences in plasma concentrations of electrolytes, urea or creatinine between CGP 29,287-treated and control marmosets. These results indicate that although renin release is markedly stimulated after continuous administration of a renin inhibitor for 7 days, the formation of Ang II and aldosterone, the active hormones of the renin-angiotensin system, is substantially reduced.
No takes yet. Share an insight, caveat, or question.
Wood et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: